Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 19;140(17):1875–1890. doi: 10.1182/blood.2021015036

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by The American Society of Hematology.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure 2. — Transcriptional reprogramming in lineage-switched and MPAL cases. (A) Heat map showing the top 100 differentially expressed genes between ALL and AML from 6 lineage-switched (LS01, LS03, LS04, LS05, LS06, and LS10) and 2 MPAL cases, ranked by Wald statistics. (B) Enrichment of myeloid growth and differentiation signature in relapse samples (left) identified by gene set enrichment analyses (GSEA), also pointing to downregulation of genes highly correlating with acute lymphoblastic leukemia (middle and right). GSEAs were performed based on data derived from 6 lineage-switched samples. FDR, false-discovery rate; NES, normalized enrichment score. Differential expression of lineage-specific (C) and immunoglobulin recombination machinery genes (D) in lineage-switched and MPAL cases. Error bars show standard error of the mean for lineage-switched cases and ranges for 2 MPAL cases.